This inventor holds 1 USPTO granted patent. Top assignee: Hongyun Biotech Co., Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Caihong Yun and EGFR-Targeted Pharmaceutical Innovation.
Introduction
Caihong Yun is an inventor based in Beijing, China, associated with Hongyun Biotech Co., Ltd. Her patent work includes research into compounds that inhibit epidermal growth factor receptor (EGFR) activity, a target relevant to cancer and other diseases.
Latest Patents
The supplied information lists 1 patent for Yun: “Alkenyl Pyrimidine Compound, Preparation Method Therefor, and Application Thereof.” The invention concerns an alkenyl pyrimidine compound, its pharmaceutically acceptable salts or solvates, methods for preparing it, and pharmaceutical compositions containing it. It also describes potential use in medicines for preventing or treating cancer and other diseases mediated by EGFR kinase.
Career Highlights
Yun’s listed patent reflects work at the intersection of medicinal chemistry and drug development. Its focus on EGFR inhibition connects the compound’s proposed applications to a well-established area of pharmaceutical research.
Collaborations
The supplied information names Xianming Deng and Yachuang Wu as Yun’s coworkers. It does not specify their roles in the patent or the nature of their collaboration.
Conclusion
Caihong Yun’s listed invention centers on an EGFR-inhibiting alkenyl pyrimidine compound and its potential pharmaceutical applications, highlighting her contribution to patent activity in drug research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile